Decreased Sensitivity of Platelets to Platelet-Activating Factor in Migraine Patients During the Headache-Free Interval

• References

• 1 Hanington E. The platelet and migraine. Headache 1986; 26: 411-415
• 2 Steiner TJ, Joseph R, Clifford Rose F. Migraine is not a platelet disorder. Headache 1985; 25: 434-440
• 3 Bartleson JP. Transient and persistent neurological manifestations of migraine. Stroke 1984; 15: 383-386
• 4 Mathew NT. Computerized axial tomography in migraine. In: Current Concepts in Migraine Research. Greene R. (ed) Raven Press; New York: 1978: 63-72
• 5 Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in plateletactivating factor research. Pharmacol Rev 1987; 39: 97-145
• 6 Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in mongolian gerbils. Prostaglandins 1987; 34: 337-348
• 7 Filep J, Hermán F, Braquet P, Mozes T. Increased levels of plateletactivating factor in blood following intestinal ischemia in the dog. Biochem Biophys Res Commun 1989; 158: 353-359
• 8 Buttinelli C, Lazzaro MP, Lenzi GL, Paolucci S, Prencipe M. Correlation between migraine and circulating platelet aggregates. Cephalalgia 1985; Suppl. 2: 87-88
• 9 Joseph R, Welch KM A, D’Andrea G, Levine SR. Sensitivity to PAF is increased in migraine patients. Thromb Haemostas 1987; 57: 125